Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Cerebral Edema ll: Pathophysiology

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Veins of Head and Neck

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...

Cerebral Edema l: Introduction

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study.

Journal of thrombosis and haemostasis : JTH·2025

Same author

Gene-Gene Interaction Between Factor-<i>XI</i> and <i>ABO</i> Genes in Cerebral Venous Thrombosis: The BEAST Study.

Neurology·2024

Same author

Prediction of venous thromboembolism in average-risk, young candidates for oral contraceptive use: to genotype, or not to genotype, that is the question.

American journal of obstetrics and gynecology·2024

Same author

Coma in adult cerebral venous thrombosis: The BEAST study.

European journal of neurology·2024

Same author

Post-lumbar puncture cerebral vein thrombosis.

EJHaem·2024

Same author

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor.

International journal of molecular sciences·2023

Search research articles

Related Experiment Video

Updated: May 13, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

Cerebral vein thrombosis.

Ida Martinelli¹

¹A. Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Medical Specialities, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. martin@policlinico.mi.it

Thrombosis Research

|March 5, 2013

Summary

This summary is machine-generated.

Cerebral vein thrombosis (CVT) affects 3-4 adults per million annually. Early diagnosis and anticoagulation improve survival, though optimal treatment duration remains unclear.

Related Experiment Videos

Last Updated: May 13, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

Area of Science:

Neurology
Vascular Medicine
Hematology

Background:

Cerebral vein thrombosis (CVT) is a rare condition with an estimated annual incidence of 3-4 cases per million in adults.
Risk factors include oral contraceptive use, pregnancy, puerperium, cerebral tumors, infections, and trauma, with higher prevalence in women.
A significant percentage (15-20%) of CVT cases are unprovoked, necessitating investigation into underlying coagulopathies like thrombophilia and hyperhomocysteinemia.

Purpose of the Study:

To summarize the epidemiology, risk factors, and clinical management of cerebral vein thrombosis (CVT).
To highlight the importance of investigating thrombophilia and other potential causes in unprovoked CVT.
To discuss recurrence rates and the impact of early diagnosis and treatment on patient outcomes.

Main Methods:

Review of existing literature on cerebral vein thrombosis (CVT) incidence, risk factors, and management strategies.
Analysis of clinical data pertaining to patient demographics, identified risk factors, and treatment outcomes.
Synthesis of information regarding diagnostic approaches and therapeutic interventions for CVT.

Main Results:

CVT incidence is low but significant, with distinct risk factors in adults and neonates.
Hormonal factors (oral contraceptives, pregnancy) are prominent in women, while local factors and unprovoked events also contribute.
Coagulation abnormalities and myeloproliferative neoplasms are potential underlying causes in some patients.
Recurrence of CVT is low, but venous thromboembolism in other sites can occur, especially after idiopathic CVT.

Conclusions:

Early diagnosis and prompt anticoagulant therapy are crucial for reducing morbidity and improving survival in CVT patients.
Investigating thrombophilia and other prothrombotic states is essential, particularly in unprovoked or recurrent cases.
Further research is needed to establish optimal anticoagulant treatment duration for CVT to balance efficacy and safety.